📰 Protocol Amendment News
Protocol Amendment News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Protocol Amendment. Real-time updates on events, politics, business and more.
April 10, 2024
Experts say more clarity needed with regard to applicability of DTAA provisions
June 30, 2023
/PRNewswire/ -- The "CNS Therapeutics: Global Strategic Business Report" report has been added to ResearchAndMarkets.coms offering. The global market for CNS...
June 30, 2023
DUBLIN, June 30, 2023 /PRNewswire/ -- The "CNS Therapeutics: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global market for CNS Therapeutics estimated
January 4, 2023
FY2022 top line revenue expected to end the year at ~$80 million, in line with previously announced revenue guidanceFY2023 revenue guidance range set between $90 million and $95 million, ending
January 7, 2022
Completed Patient Enrollment for Part A of Phase 2 INTEGRAL Trial Evaluating THR-687 for treatment of Diabetic Macular Edema (DME) in treatment naïve subjects US IRB Approval of Protocol Amendment
January 7, 2022
Completed Patient Enrollment for Part A of Phase 2 INTEGRAL Trial Evaluating THR-687 for treatment of Diabetic Macular Edema (DME) in treatment naïve...